Tirzepatide Popular
Metabolic Research

Tirzepatide

Dual GIP / GLP-1 Receptor Agonist

A dual GIP and GLP-1 receptor agonist reference compound for incretin research.

Starting at $129
Available sizes
10 mg 30 mg

Sold for laboratory research use only. Not for human or veterinary use.

CAS number
2023788-19-2
Purity
≥ 99.0% (HPLC)
Molecular formula
C225H348N48O68
Molecular weight
4813.45 g/mol
Available sizes
10 mg · 30 mg
Form
Lyophilised powder, sealed vial
Documentation
Lot-specific COA (HPLC + MS)

Description

Tirzepatide is a 39-residue synthetic peptide engineered for dual GIP/GLP-1 receptor activity, with a C20 diacid side chain for albumin binding. Used as an analytical reference standard in incretin receptor research.

Every lot is accompanied by an independent third-party COA documenting HPLC purity, ESI-MS identity and residual water content.

Storage & handling

Store at −20 °C, desiccated and protected from light. Avoid repeated freeze-thaw cycles.

Quality documentation

Each lot is released against a written specification. The certificate of analysis supplied with your order includes the HPLC chromatogram, calculated purity, mass-spectrometry result and the theoretical versus observed molecular weight.

  • Reverse-phase HPLC purity, reported to one decimal place.
  • ESI-MS identity confirmation against the theoretical mass.
  • Lot number printed on the vial, matching the certificate.
  • SDS and handling guidance available on request.
Request the current lot COA